This inventor holds 1 USPTO granted patent. Top assignee: St. Jude Children's Research Hospital. Active years: 2019.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2019
Title: Innovations in Cancer Treatment by Wai-Hang Leung
Introduction
Wai-Hang Leung is an accomplished inventor based in Memphis, TN (US). He has made significant contributions to the field of cancer treatment through his innovative research and development. His work focuses on the use of specific receptor agonists and antagonists to combat cancer effectively.
Latest Patents
Wai-Hang Leung holds a patent for "Retinoid X receptor-gamma agonists and retinoid X receptor-alpha antagonists for treatment of cancer." This invention is directed towards utilizing Retinoid X Receptor-gamma (RXR-gamma) agonists and Retinoid X Receptor-alpha (RXR-alpha) antagonists in the treatment of cancer. His groundbreaking work in this area has the potential to improve therapeutic outcomes for cancer patients.
Career Highlights
Wai-Hang Leung is affiliated with St. Jude Children's Research Hospital, where he continues to advance his research in pediatric oncology. His dedication to improving cancer treatment for children is commendable and highlights his commitment to making a difference in the lives of young patients.
Collaborations
Wai-Hang Leung collaborates with Wing Leung, who is also a key figure in his research endeavors. Their partnership exemplifies the importance of teamwork in scientific research and innovation.
Conclusion
Wai-Hang Leung's contributions to cancer treatment through his innovative patent and work at St. Jude Children's Research Hospital demonstrate his commitment to advancing medical science. His research holds promise for improving the lives of many patients facing cancer.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile